Paion AG

Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and critical care services worldwide. The company's lead product is Remimazolam, an ultra-short-acting intravenous benzodiazepine sedative/anesthetic, which is in clinical development for use in procedural sedation, general anesthesia, and intensive care unit sedation. Show More...

  • Website https://www.paion.com
  • Sector Healthcare
  • Industry Drug Manufacturers-Specialty & Generic
  • Last Quote 0.02 USD
  • Last Updated 09-05-2025
  • External Links Yahoo Finance Morningstar Ratios
  •   2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 2020-12 TTM
    Earnings Per Share EUR -0.44 0.51 -0.07 -0.22 -0.55 -0.37 -0.2 -0.16 -0.11 0.03 0.03
    Dividends EUR
    Payout Ratio % *
    Shares Mil 31.0 31.0 31.0 41.0 52.0 54.0 61.0 64.0 66.0 67.0 67.0
    Book Value Per Share * USD 0.32 0.66 0.39 0.3 0.45 0.37
    Free Cash Flow Per Share * USD -0.24 0.65 -0.24 -0.46 -0.27 -0.39 -0.26 -0.02 0.03
    Return on Assets % -69.39 78.2 -9.54 -21.53 -51.29 -49.4 -34.62 -35.37 -28.5 8.38 8.38
    Financial Leverage (Average) 1.82 1.35 1.06 1.22 1.52 1.26 1.17 1.69 1.32 1.32
    Return on Equity % -237.88 211.92 -15.31 -23.98 -57.48 -66.5 -48.21 -43.17 -39.47 12.34 12.34
    Return on Invested Capital % -226.68 109.93 -12.55 -24.12 -57.55 -66.55 -48.27 -43.19 -31.18 11.5 11.5
    Interest Coverage -17.28 436.13 -992.37 -75.57 9.78 9.78
    Current Ratio 2.71 2.07 3.09 16.06 5.07 2.69 4.41 6.29 2.23 3.84 3.84
    Quick Ratio 2.41 2.02 2.85 15.13 4.14 2.31 3.74 5.35 1.93 2.95 2.95
    Debt/Equity